The cardiovascular ultrasound system market size is estimated to be USD 2,781.5 billion in 2022 and is expected to witness a CAGR of 7.85% during the forecast period 2023-2033. The rising technical growth, benefits of non-invasive cardiac diagnostic methods over echocardiography, and rising CVD prevalence are factors contributing to the market growth. However, financial effects of implementing new technology is expected to hinder the growth.

Segmentation

By Device Display

Based on device display, the market is bifurcated into black & white (b/w) display, and colour display. In 2022, the colour display segment held the highest market share owing to the colour devices are often chosen over B/W systems because of the quality of pictures provided by these platforms, and an improved diagnosis is achieved using color cardiovascular ultrasound.

By Technology

On the basis of technology, the market is segregated into doppler imaging, 3D & 4D, and 2D. In 2022, the 3D & 4D segment held the highest market share due to rising use of cutting-edge technology in emerging nations and this technique offers greater image resolution.

By Test Type

Based on test type, the market is divided into stress echocardiogram, transesophageal echocardiogram, transthoracic echocardiogram, and other echocardiograms. In 2022, the stress echocardiogram segment held the highest market share owing to the benefits of a stress echocardiography include the ability to give data on the heart muscle and valves during and after the heart muscle has been stressed.

 By End User

On the basis of end user, the market is categorized into ambulatory/home care, hospitals/cardiology centers, research institute and other end users. In 2022, the ambulatory/home care segment held the highest market share due to a rise in the utilization of echocardiographs at the client’s home.

Regional Markets

In 2022, North America region accounted for the highest revenue in the cardiovascular ultrasound system market and is expected to maintain its dominance during the forecast period. This is attributed to the expanded use of CVUS in preventative care and the upgraded facilities in healthcare institutions, and the favourable regulatory and reimbursement structure. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the rising incidence of chronic diseases in this region.

Competitor Insights

Some of the key players operating in the cardiovascular ultrasound system market are Abbott (US), ATYS MEDICAL(France), Boston Scientific Corporation (US), FUJIFILM Corporation (Japan), GE Healthcare (U.S.), Hitachi Medical Corporation (Japan), KPI Healthcare India Pvt. Ltd. (India), Medtronic (Ireland), Philips healthcare (The Netherlands), SAMSUNG (South Korea), Siemens Healthcare (Germany), Stryker (US), Toshiba Medical Systems Corporation (Japan), Trivitron Healthcare (India), and Whale Imaging (US).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including device display, technology, test type, and end user from 2023 to 2033.

Report Scope:

Segmentation: Cardiovascular Ultrasound System Market Report 2022 – 2033

Device Display (Revenue, USD Billion), 2022 – 2033

• Black & White (B/W) Display
• Color Display

Technology (Revenue, USD Billion), 2022 – 2033

• Doppler Imaging
• 3D & 4D
• 2D

Test Type (Revenue, USD Billion), 2022 – 2033

• Stress Echocardiogram
• Transesophageal Echocardiogram
• Transthoracic Echocardiogram
• Other Echocardiograms

End User (Revenue, USD Billion), 2022 – 2033

• Ambulatory/Home Care
• Hospitals/Cardiology Centers
• Research Institute
• Other End Users

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA